Clinical Outcomes of Robot-assisted Endoscopic Lumbar Interbody Fusion Compared With Transforaminal Lumbar Interbody Fusion for Single-level Lumbar Degenerative Disease
BACKGROUND: This study compared the clinical outcomes of robot-assisted endoscopic lumbar interbody fusion (RA-Endo-LIF) with those of traditional transforaminal lumbar interbody fusion (TLIF) in patients with single-level lumbar degenerative disease. MATERIALS AND METHODS: We conducted a retrospective analysis of 66 patients who underwent surgery for single-level lumbar degenerative disease between July 2023 and January 2025. Patients were assigned to either the RA-Endo-LIF group (n = 35) or the TLIF group (n = 31) based on the surgical technique performed. Data on incision length, operative time, intraoperative fluoroscopy frequency, blood loss, postoperative drainage volume, time to ambulation, and length of hospital stay were collected and analyzed. Clinical outcomes were evaluated pre- and postoperatively using the visual analog scale (VAS), Oswestry Disability Index (ODI), Japanese Orthopaedic Association (JOA) scores, and intervertebral disk height. RESULTS: > .05). CONCLUSION: The RA-Endo-LIF technique offers distinct minimally invasive advantages. It provides short-term pain relief and functional improvement comparable to TLIF. However, its longer operative time and steep learning curve warrant consideration. Further validation through larger sample sizes and long-term follow-up is required.
Authors
- Yufu Ou
- Hua Li
- Jiang Xue
- Yong Zhao
- Longao Huang
- Jiawen Sun
Institutions
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
- Luohe Medical College (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Orthopedics
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3928/01477447-20261008-01
- Primary Topic
- Spine and Intervertebral Disc Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00